Effectiveness of Ramucirumab Plus Docetaxel for Advanced Non-Small Cell Lung Cancer Patients: a Cohort of 93 Patients

被引：0
|
作者：
Barcelos, Isabella Favato [1 ]
De Marchi, Pedro [1 ]
Aguiar Junior, Pedro Nazareth [1 ]
Montella, Tatiane Caldas [1 ]
Afonso, Nathalia Gimenes [1 ]
Visani, Filipe [1 ]
Negreiros, Izabella Santos [1 ]
De Cerqueira Mathias, Clarissa Maria [1 ]
Paes, Rafael Duarte [1 ]
Dienstmann, Rodrigo [1 ]
Ferreira, Carlos Gil [1 ]
机构：
[1] Oncoclin, Rio De Janeiro, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.11
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [31] A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer
    Govindan, R
    Lim, WT
    Arquette, MA
    Goodner, SA
    Fears, CL
    Mortimer, JE
    Fracasso, PM
    ONCOLOGY REPORTS, 2006, 15 (01) : 123 - 127
  • [32] Evaluation of irinotecan plus paclitaxel in patients with advanced non-small cell lung cancer
    Murren, JR
    Andersen, N
    Psyrri, D
    Brandt, D
    Nadkarni, R
    Rose, M
    Davies, MJ
    Parisot, N
    Rosenfield, AT
    Pizzorno, G
    Zelterman, D
    CANCER BIOLOGY & THERAPY, 2005, 4 (12) : 1311 - 1315
  • [33] Docetaxel in the management of advanced non-small cell lung cancer
    Miller, VA
    SEMINARS IN ONCOLOGY, 1998, 25 (03) : 15 - 19
  • [34] Docetaxel (Taxotere®) plus cisplatin:: an active and well-tolerated combination in patients with advanced non-small cell lung cancer
    Le Chevalier, T
    Monnier, A
    Douillard, JY
    Ruffie, P
    Sun, XS
    Belli, L
    Ibrahim, N
    Bougon, N
    Bérille, J
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (13) : 2032 - 2036
  • [35] Effectiveness of Endoluminal Photodynamic Therapy in Patients With Advanced Non-small Cell Lung Cancer
    Chhatre, Sumedha
    Ross, Patrick
    Jayadevappa, Ravishankar
    CHEST, 2016, 150 (04) : 722A - 722A
  • [36] Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer
    Katayama, Yuki
    Yamada, Tadaaki
    Sawada, Ryo
    Kawachi, Hayato
    Morimoto, Kenji
    Watanabe, Satoshi
    Watanabe, Kageaki
    Takeda, Takayuki
    Chihara, Yusuke
    Shiotsu, Shinsuke
    Hibino, Makoto
    Harada, Taishi
    Nishioka, Naoya
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    ONCOLOGIST, 2024, : e681 - e689
  • [37] Weekly administration of gemcitabine plus docetaxel in advanced non-small cell lung cancer (NSCLC).
    Sun, Y
    Li, J
    Wu, Y
    Li, L
    Gu, L
    Zhang, L
    Wang, J
    Zhang, X
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [38] Simultaneous chylous ascites and chylothorax during ramucirumab plus docetaxel chemotherapy in a patient with non-small lung cell cancer
    Arai, Makoto
    Maruta, Susumu
    Fan, Meng Meng
    Imai, Chiaki
    Tawada, Akinobu
    Takiguchi, Yuichi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2019, 8 (03) : 114 - 117
  • [39] The Impact of EGFR Mutation Status and Brain Metastasis for Non-Small Cell Lung Cancer Treated with Ramucirumab plus Docetaxel
    Furuya, Naoki
    Ito, Kentaro
    Sakaguchi, Tadashi
    Hida, Naoya
    Kakinuma, Kazutaka
    Morikawa, Kei
    Inoue, Takeo
    Komase, Yuko
    Hataji, Osamu
    Mineshita, Masamichi
    ONCOLOGY, 2020, 98 (09) : 661 - 668
  • [40] Simultaneous chylous ascites and chylothorax during ramucirumab plus docetaxel chemotherapy in a patient with non-small lung cell cancer
    Makoto Arai
    Susumu Maruta
    Meng Meng Fan
    Chiaki Imai
    Akinobu Tawada
    Yuichi Takiguchi
    International Cancer Conference Journal, 2019, 8 : 114 - 117
12345